We only have this paper's title and publication details.
Read it at the sourceCaptured external expert commentary on this paper, strongest first. Original sources are linked where available.
“Our thinking about this disease has evolved. We now better understand the interplay of risk factors involved in both the progression of the disease and the occurrence of adverse events such as heart attack and cardiac death. With this new guideline, we have transitioned from arbitrarily picking and choosing individual therapies to recognizing there is a package of lifestyle modifications and medications—what we call guideline-directed medical therapy—that benefits most patients.”
“Overall, there is a misperception that somehow opening up and stenting an artery saves lives for patients with stable disease; however, in the majority of these cases, there is no evidence from any study that this procedure prolongs life.”
“The writing committee has done a masterful job of imparting balance, emphasizing the importance of risk-factor identification, lifestyle intervention, and of treating intensively with respect to secondary prevention.”
No takes yet. Share an insight, caveat, or question.
Fihn et al. (2012) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: